60‐day mortality ‐ Recombinant factor VIIa (rFVIIa) versus control · Patients with liver transplantation.
It is very uncertain whether intervention changes 60‐day mortality ‐ Recombinant factor VIIa (rFVIIa) versus control compared with control (very low certainty).
1 finding from 1 review
60‐day mortality ‐ Tranexamic acid versus aprotinin · Patients with liver transplantation.
It is very uncertain whether intervention changes 60‐day mortality ‐ Tranexamic acid versus aprotinin compared with control (very low certainty).
1 finding from 1 review
Intervention not reported
Treatment failure at 8 to 19 days · patients with acute otitis media
The intervention led to higher treatment failure at 8 to 19 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 20 to 30 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 20 to 30 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 8 to 19 days · patients with acute otitis media
The intervention led to higher treatment failure at 8 to 19 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 20 to 30 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 20 to 30 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 90 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 90 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 30 to 45 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 30 to 45 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
A time halo effect lasted for 3 days following a single application of enforcement. With 5 days of consecutive enforcement a time halo of at least 6 days was noted. At the site of speed limit enforcement the average speed was reduced to around the...
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
Reduction in average speeds by 0.9 to 4.8 km/h for all times of day reported. 10% reduction in proportion of speeding drivers. A time halo effect of up to 8 weeks was shown.
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
About 70% reduction in speeding vehicles when police present. A time halo effect lasted at least 2 days.
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
23% crash reduction during the day and a 21% reduction at other times.
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
Overall mean speed reduction of about 2‐3km/h seen at both experimental and control sites. Distance halo of up to 14km downstream was seen. Time halo for at least the day after enforcement.
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
A net reduction of 71.3 % (p = 0.064) in injury crashes up to and including 4 days after the presence of enforcement. A net reduction of 73.9% (p =0.045) on the day when a mix of overt/covert enforcement employed.
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
A 25% reduction in expected crash rate, 11% reduction in injury crashes and a 17% reduction in daytime crash fatalities.
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
About 25% reduction in crashes to that expected. A significant 11% reduction in number of victims, with an average decrease of 139 daytime traffic crashes requiring an ambulance. A 17% reduction in daytime crash fatalities.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hot flush frequency (number/day) · patients with hot flushes in women with a history of breast cancer
1 finding from 1 review
Hot flush frequency (number/day) · patients with hot flushes in women with a history of breast cancer
1 finding from 1 review
AW symptoms (CIWA‐Ar score) · people with alcohol withdrawal
1 finding from 1 review
AW symptoms (CIWA‐Ar score) · people with alcohol withdrawal
1 finding from 1 review